U.S. Markets open in 7 hrs, 55 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,058.64 | 150.25 | 1.52% |
| NASDAQ | 2,150.87 | 24.82 | 1.17% |
| S&P 500 | 1,070.52 | 13.78 | 1.30% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 54.625 11:09 AM EST | |
|---|---|---|
| Day High | 56.62 09:33 AM EST |
|
| Range | 1.99 |
| Volume | 934,187 | |
|---|---|---|
| 30-Day Avg Vol | 915,000 |
|
| Difference | 2.10% |
| Market Cap | 3.52 B | |
|---|---|---|
| Mkt Cap Chg | -19.20 M |
| Shares Out | 64.02 M | |
|---|---|---|
| % Shrs Traded | 1.46% | |
| 1yr EPS Est | 2.696 |
| 52-Wk Low | 32.31 | |
|---|---|---|
| 52-Wk High | 61.59 |
|
| Range | 29.28 |
| Prev Close | 55.43 2/8/10 | |
|---|---|---|
| Today's Open | 55.82 | |
| Change | 0.70% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 7.1 M |
| Revenue (LFY) | 1.96 B | |
|---|---|---|
| Earnings (LFY) | 175.88 M | |
| Earnings (MRQ) | 41.54 M | |
| Next Earn Est | 0.605 | |
| Next Earnings | 04/26/2010 |
|
| EPS (TTM) | 2.73 | |
| 1yr EPS Growth | 3.69% |
| P/E Ratio (TTM) | 21.20 | |
|---|---|---|
| P/E Ratio (Fwd) | 20.00 | |
| PEG Ratio | 1.52 | |
| Return on Equity | 17.20 | |
| Beta | 1.05 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Health Services |
above for more info
Behind every great drug company stands a great contract research organization (CRO), and Covance is one of the biggest. Covance helps pharmaceutical and biotech companies develop new drugs, providing preclinical ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | 0.605 4/26/10 | — — |
—
—
|
| Last Quarter | 0.651 12/31/09 | 0.64 12/31/09 |
-0.011
Missed
|
| 2 Quarters Ago | 0.669 9/30/09 | 0.67 9/30/09 |
0.001
Beat
|
| Quarterly - 12/31/2009 | Annual - 2009 | |
|---|---|---|
| Total Revenue | 507.33 M | 1.96 B |
| Gross Profit | 144.68 M | 594.20 M |
| Operating Income | 54.87 M | 228.61 M |
| Net Income | 41.54 M | 175.88 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts